End-of-day quote
Shanghai S.E.
06:00:00 2024-07-16 pm EDT
|
5-day change
|
1st Jan Change
|
6.77
CNY
|
+0.30%
|
|
+1.50%
|
-42.92%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,730
|
13,010
|
13,274
|
11,866
|
12,111
|
6,913
|
-
|
-
|
Enterprise Value (EV)
1 |
9,730
|
12,118
|
12,237
|
11,312
|
11,980
|
6,964
|
6,784
|
7,135
|
P/E ratio
|
38.1
x
|
30.9
x
|
25.8
x
|
21.5
x
|
30
x
|
14.7
x
|
10.9
x
|
10.1
x
|
Yield
|
0.82%
|
0.98%
|
1.16%
|
1.55%
|
1%
|
2.48%
|
2.99%
|
2.81%
|
Capitalization / Revenue
|
2.36
x
|
2.6
x
|
2.5
x
|
2.01
x
|
2.24
x
|
1.14
x
|
1
x
|
0.93
x
|
EV / Revenue
|
2.36
x
|
2.42
x
|
2.31
x
|
1.92
x
|
2.22
x
|
1.15
x
|
0.98
x
|
0.96
x
|
EV / EBITDA
|
19.3
x
|
14
x
|
13.3
x
|
12.7
x
|
17.1
x
|
7.45
x
|
5.82
x
|
5.64
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.36
x
|
2.9
x
|
2.7
x
|
2.24
x
|
2.19
x
|
1.17
x
|
1.07
x
|
1
x
|
Nbr of stocks (in thousands)
|
1,009,951
|
1,015,611
|
1,015,611
|
1,021,148
|
1,021,148
|
1,021,148
|
-
|
-
|
Reference price
2 |
9.634
|
12.81
|
13.07
|
11.62
|
11.86
|
6.770
|
6.770
|
6.770
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,118
|
4,999
|
5,302
|
5,892
|
5,406
|
6,048
|
6,946
|
7,397
|
EBITDA
1 |
505.2
|
864.9
|
920.4
|
890
|
699.2
|
934.5
|
1,165
|
1,266
|
EBIT
1 |
328.9
|
673
|
664.3
|
622.1
|
402.8
|
597.7
|
786.9
|
850.9
|
Operating Margin
|
7.99%
|
13.46%
|
12.53%
|
10.56%
|
7.45%
|
9.88%
|
11.33%
|
11.5%
|
Earnings before Tax (EBT)
1 |
344.1
|
536
|
669.2
|
626.5
|
406.4
|
556.2
|
747.9
|
804.9
|
Net income
1 |
255.5
|
420.4
|
513.9
|
550.1
|
403.1
|
470.4
|
633.9
|
684.3
|
Net margin
|
6.21%
|
8.41%
|
9.69%
|
9.34%
|
7.46%
|
7.78%
|
9.13%
|
9.25%
|
EPS
2 |
0.2530
|
0.4148
|
0.5060
|
0.5401
|
0.3947
|
0.4613
|
0.6216
|
0.6716
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0792
|
0.1250
|
0.1520
|
0.1800
|
0.1190
|
0.1677
|
0.2027
|
0.1901
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
|
2,597
|
1,529
|
1,766
|
3,295
|
-
|
-
|
1,651
|
1,247
|
2,898
|
-
|
-
|
2,662
|
-
|
-
|
3,376
|
3,435
|
3,685
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
314.3
|
-
|
158.5
|
307.8
|
-
|
-
|
136.7
|
-18.09
|
118.6
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
12.1%
|
-
|
8.98%
|
9.34%
|
-
|
-
|
8.28%
|
-1.45%
|
4.09%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
149.6
|
-
|
140.5
|
-
|
128
|
6.094
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
8.47%
|
-
|
-
|
-
|
7.75%
|
0.49%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
0.1400
|
0.1500
|
-
|
0.1376
|
0.2634
|
0.1300
|
0.001300
|
0.1300
|
-
|
-
|
0.1300
|
-
|
-
|
0.2100
|
0.2500
|
0.2600
|
Dividend per Share
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1190
|
-
|
-
|
-
|
-
|
-
|
0.2124
|
-
|
-
|
-
|
Announcement Date
|
8/17/22
|
10/28/22
|
4/21/23
|
4/21/23
|
4/28/23
|
8/30/23
|
10/30/23
|
4/9/24
|
4/9/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
50.6
|
-
|
221
|
Net Cash position
1 |
-
|
892
|
1,037
|
553
|
131
|
-
|
130
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.0542
x
|
-
|
0.1749
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.29%
|
9.61%
|
10.8%
|
10.6%
|
7.46%
|
7.99%
|
9.8%
|
9.3%
|
ROA (Net income/ Total Assets)
|
4.08%
|
6.66%
|
7.19%
|
-
|
4.77%
|
5.64%
|
6.5%
|
6.66%
|
Assets
1 |
6,267
|
6,312
|
7,144
|
-
|
8,442
|
8,340
|
9,756
|
10,275
|
Book Value Per Share
2 |
4.080
|
4.410
|
4.840
|
5.190
|
5.410
|
5.770
|
6.320
|
6.760
|
Cash Flow per Share
2 |
0.0300
|
0.6600
|
0.3800
|
-0.2200
|
0.3600
|
0.7300
|
0.7600
|
0.7500
|
Capex
1 |
424
|
531
|
476
|
426
|
638
|
489
|
463
|
325
|
Capex / Sales
|
10.29%
|
10.63%
|
8.98%
|
7.23%
|
11.81%
|
8.08%
|
6.66%
|
4.4%
|
Announcement Date
|
4/20/20
|
3/30/21
|
4/14/22
|
4/21/23
|
4/9/24
|
-
|
-
|
-
|
Last Close Price
6.77
CNY Average target price
11.3
CNY Spread / Average Target +66.91% Consensus |
1st Jan change
|
Capi.
|
---|
| -42.92% | 952M | | -7.76% | 83.07B | | -12.42% | 6.45B | | +35.38% | 4B | | -2.78% | 3.2B | | +19.76% | 1.76B | | -1.56% | 1.3B | | -37.70% | 1.03B | | -18.24% | 854M | | -33.66% | 865M |
Veterinary Drugs
|